AMPHIREGULIN AND EPIREGULIN POLYMORPHISMS AS PHARMACOGENETIC PREDICTIVE FACTORS FOR RESPONSE TO IRINOTECAN PLUS ANTI-EGFR TREATMENT

被引：0
|
作者：
Sebio Garcia, A. [1 ]
Paez, D. [1 ]
Salazar Blanco, J. [1 ]
Tobena Puyal, M. [1 ]
Martin-Richard, M. [1 ]
Barnadas, A. [1 ]
Baiget, M. [1 ]
机构：
[1] Santa Creu & St Pau Hosp, Deparment Genet, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [31] Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer
    Takahashi, N.
    Yamada, Y.
    Furuta, K.
    Honma, Y.
    Iwasa, S.
    Takashima, A.
    Kato, K.
    Hamaguchi, T.
    Shimada, Y.
    BRITISH JOURNAL OF CANCER, 2014, 110 (11) : 2716 - 2727
  • [32] CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Kang, Sora
    Kim, Sun Young
    Hong, Yong Sang
    Kim, Tae Won
    Choi, Ki Eun
    Kim, Min Jung
    Kim, Jeong Eun
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [33] The Long and Winding Road to Useful Predictive Factors for Anti-EGFR Therapy in Metastatic Colorectal Carcinoma: The KRAS/BRAF Pathway
    Russo, Antonio
    Rizzo, Sergio
    Bronte, Giuseppe
    Silvestris, Nicola
    Colucci, Giuseppe
    Gebbia, Nicola
    Bazan, Viviana
    Fulfaro, Fabio
    ONCOLOGY, 2009, 77 : 57 - 68
  • [34] Influence of mRNA expression of epiregulin (EREG) and of amphiregulin (AREG) and RAS mutationson outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).
    Stahler, Arndt
    Heinemann, Volker
    Giessen, Clemens Albrecht
    Crispin, Alexander
    Schalhorn, Alexander
    Stintzing, Sebastian
    von Weikersthal, Ludwig Fischer
    Vehling-Kaiser, Ursula
    Stauch, Martina
    Qietzsch, Detief
    Neumann, Jens
    Kirchner, Thomas
    Jung, Andreas
    Modest, Dominik Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Influence of mRNA expression of Epiregulin (EREG) and of Amphiregulin (AREG) and RAS mutations on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial)
    Stahler, A.
    Heinemann, V
    Giessen, C.
    Crispin, A.
    Schalhorn, A.
    Stintzing, S.
    von Weikersthal, Fischer L.
    Vehling-Kaiser, U.
    Stauch, M.
    Quietzsch, D.
    Neumann, J.
    Kirchner, T.
    Jung, A.
    Modest, D. P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 81 - 81
  • [36] Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma (vol 117, pg 1819, 2018)
    Lievre, Astrid
    Ouine, Berengere
    Canet, Jim
    Cartier, Aurelie
    Amar, Yael
    Cacheux, Wulfran
    Mariani, Odette
    Guimbaud, Rosine
    Selves, Janick
    Lecomte, Thierry
    Guyetant, Serge
    Bieche, Ivan
    Berger, Frederique
    de Koning, Leanne
    BRITISH JOURNAL OF CANCER, 2018, 119 (03) : 387 - 387
  • [37] Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Tougeron D.
    Cortes U.
    Ferru A.
    Villalva C.
    Silvain C.
    Tourani J.M.
    Levillain P.
    Karayan-Tapon L.
    Cancer Chemotherapy and Pharmacology, 2013, 72 (2) : 397 - 403
  • [38] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment:a meta-analysis
    Wei-Dong Shen
    Hong-Lin Chen
    Peng-Fei Liu
    Chinese Journal of Cancer Research, 2014, 26 (01) : 59 - 71
  • [39] CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Sora Kang
    Sun Young Kim
    Yong Sang Hong
    Tae Won Kim
    Ki Eun Choi
    Min Jung Kim
    Jeong Eun Kim
    Scientific Reports, 13
  • [40] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis
    Shen, Wei-Dong
    Chen, Hong-Lin
    Liu, Peng-Fei
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : 59 - 71
12345